Migraine Disorders

Migraine is described as having an inherited tendency, indicating a hereditary predisposition. The supplied grounding does not support a single external cause or a fully defined aetiology beyond this inherited susceptibility.

Migraine is presented as a neurological disorder of sensory processing involving abnormal control of sensory inputs by the brain. The literature highlights the trigeminovascular system, cerebral cortex, cortical spreading depression, central nervous system sensitization, and neuropeptides such as calcitonin gene-related peptide as important components of attack biology. It is also described as involving interactions between peripheral and central nervous systems, with neuronal and glial changes contributing to altered excitatory and inhibitory balance.

Female sex is noted in the supplied reviews as being associated with higher frequency in adulthood. The grounding also supports hereditary susceptibility as a risk factor for developing migraine. No other risk factors are directly supported by the supplied material.

The supplied grounding supports therapy at the modality and drug-class level, but it does not name specific treatments. It indicates that migraine literature covers therapy and that CGRP is a key co-studied target, consistent with treatment approaches directed at migraine biology. Beyond this, the grounding does not support a more specific standard-of-care description.